Albany, NY -- (SBWIRE) -- 02/26/2016 -- A new research report by Transparency Market Research (TMR) offers a comprehensive study and unbiased overview of the global opium tincture market. The report, titled "Opium Tincture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020," is available for sale on the firm's website.

According to the market report, opium is legally grown for medicinal purposes in India, Australia, the U.K., and Turkey. However, Afghanistan leads the global opium market in terms of production. Other significant opium producer across the world are Pakistan, Guatemala, Colombia, Mexico, and the Golden Triangle region of South East Asia.

Growing opium has been declared illegal in South American nations by their respective governments, states the report.

Get Sample for this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3769

The research report further states that the U.S. is the biggest consumer of prescription opioids - opium tincture being one of the most highly demanded prescription opiods - in the world.

Opium tincture is an alcoholic opium extract, used as a medication to control diarrhea. It contains morphine, an opioid pain reliever, which is helpful in reducing gastrointestinal motility, secretions, propulsion, and increasing gastrointestinal muscle tone.

The increasing application of opium tincture as a medicine has boosted its demand in the global pharmaceutical industry. However, reports of adverse effects of opium tincture such as dysphoria, euphoria, pruritus, miosis, constipation, sedation, reduced tidal volume, physical dependence, psychological dependence, and xerostomia have negatively impacted the market's growth.

The increasing apprehensions among consumers pertaining to the risks associated with the overdose of opium tinctures, such as severe respiratory depression or even death, are also limiting the usage of opium tincture in the global arena, notes the research study.

In addition to this, the TMR report states that the implementation of stringent rules and regulations on the use of opium tincture, in order to curtail its long term usage, will hamper the growth of this market over the forecast period.

The research report studies the global opium tincture market on the basis of the method of preparation. According to the study, the main methods of its preparation is processing opium into tinctura opii, tinctura opii camphorata (paregoric), pulvis opii (opium powder), vinum opii (herbal wine), sirupus opii (opium syrup), and extractum opii (opium extract).

The market study also provides overview of the competitive landscape prevalent in the global opium tincture market by analyzing the company profiles of the key participants operating in this market. GlaxoSmithKline, MacFarlan Smith, Johnson and Johnson, Shionogi Pharmaceutical, Johnson Matthey, Sanofi Aventis, and Mayne are the major opium tincture producers in the global arena, states the research report.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/